28 results on '"Tickoo, Satish K"'
Search Results
2. Clinical Utility of Prostate and Tumor Volume-Related Parameters Following Radical Prostatectomy for Localized Prostate Cancer
3. Clinical utility of total length Gleason pattern 4 on biopsy in men with Grade Group 2 prostate cancer
4. Pathological Stage T3a Significantly Increases Disease Recurrence across All Tumor Sizes in Renal Cell Carcinoma
5. Prognostic Impact of Subclassification of Radical Prostatectomy Positive Margins by Linear Extent and Gleason Grade
6. Renal Oncocytosis: Management and Clinical Outcomes
7. Prognostic Impact of Muscular Venous Branch Invasion in Localized Renal Cell Carcinoma Cases
8. SINGLE-INSTITUTIONAL ANALYSIS OF PATIENTS WITH CLEAR-CELL PAPILLARY RENAL CELL CARCINOMA: MP73-17
9. Tumor Size is Associated With Malignant Potential in Renal Cell Carcinoma Cases
10. Prognostic Impact of Histological Subtype on Surgically Treated Localized Renal Cell Carcinoma
11. Prostatic Transition Zone Directed Needle Biopsies Uncommonly Sample Clinically Relevant Transition Zone Tumors
12. SORBITOL AS A NOVEL MECHANISM OF HYPOXIA-INDUCIBLE FACTOR (HIF) PATHWAY ACTIVATION IN CLEAR CELL PAPILLARY RENAL CELL CARCINOMA (CCPRCC): MP35-19
13. PATHOLOGIC STAGE T3A SIGNIFICANTLY INCREASES DISEASE RECURRENCE ACROSS ALL TUMOR SIZES IN RENAL CELL CARCINOMA: MP30-18
14. Immunohistochemical Expression of Hypoxia Inducible Factor-1α and its Downstream Molecules in Sarcomatoid Renal Cell Carcinoma
15. ADVERSE OUTCOMES IN CLEAR CELL RENAL CELL CARCINOMA WITH MUTATIONS OF EPIGENETIC REGULATORS BAP1 AND SETD2: 1068
16. MORPHOLOGIC CHARACTERISTICS AT THE TIME OF PROSTATECTOMY IN LYMPH NODE POSITIVE PATIENTS: 762
17. MP86-17 THE 2017 AMERICAN JOINT COMMITTEE ON CANCER EIGHTH EDITION CANCER STAGING MANUAL: CHANGES IN STAGING GUIDELINES FOR CANCERS OF THE KIDNEY, RENAL PELVIS AND URETER, BLADDER, AND URETHRA
18. MP73-17 SINGLE-INSTITUTIONAL ANALYSIS OF PATIENTS WITH CLEAR-CELL PAPILLARY RENAL CELL CARCINOMA
19. MP35-19 SORBITOL AS A NOVEL MECHANISM OF HYPOXIA-INDUCIBLE FACTOR (HIF) PATHWAY ACTIVATION IN CLEAR CELL PAPILLARY RENAL CELL CARCINOMA (CCPRCC)
20. MP30-18 PATHOLOGIC STAGE T3A SIGNIFICANTLY INCREASES DISEASE RECURRENCE ACROSS ALL TUMOR SIZES IN RENAL CELL CARCINOMA
21. 1068 ADVERSE OUTCOMES IN CLEAR CELL RENAL CELL CARCINOMA WITH MUTATIONS OF EPIGENETIC REGULATORS BAP1 AND SETD2
22. CLEAR CELL HISTOLOGY REPRESENTS WORSE PROGNOSIS IN PATIENTS UNDERGOING SURGICAL TREATMENT FOR RENAL CELL CARCINOMA
23. TUMOR SIZE IS ASSOCIATED WITH MALIGNANT POTENTIAL IN RENAL CELL CARCINOMA
24. 1783: Active Surveillance for Small Renal Masses; what is the best Imaging Study?
25. 1301: Clinical, Pathologic and Survival Characteristics of Late Relapse Renal Cell Carcinoma
26. 628: Molecular Evidence for Hormonal Regulation of Bladder Cancer
27. 608: Increased Expression of the Polycomb Group Gene, EZH2, in Transitional Cell Carcinoma of the Bladder
28. 380: Decreased Expression of the Human Stem Cell Marker, REX-1 (ZFP-42), in Renal Cell Carcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.